Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2026-19731

low

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager…

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager allows Path Traversal. This issue affects İmzager: from 2.10.5 before 2.10.7.

CVSS
3.3
3.3 (CVSS v3.1)
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
Severity source: NVD CVSS v3.1 (iletisim@usom.gov.tr)
Timeline (UTC)
Published: 2026-11-04 09:17
Modified: 2026-11-04 14:11
NVD status: Deferred
Last synced 12 hours ago
Verified against the source API 2026-11-04 14:34 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

Not reported by the source (unknown — not "none").

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

No vendor advisory or patch reference tagged by NVD. Check the references below.

References

Data sources

NVD CVE API 2.0 — fetched 2026-11-04 14:34 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores